首页> Journal of glaucoma> Reply to "safety and efficacy of using off-label bevacizumab versus mitomycin c to prevent bleb failure in a single site phacotrabeculectomy by a randomized controlled clinical trial"

Reply to "safety and efficacy of using off-label bevacizumab versus mitomycin c to prevent bleb failure in a single site phacotrabeculectomy by a randomized controlled clinical trial"

导出原文传递

翻译打印收藏纠错

第一作者： Rewri,P.

作者： Rewri,P. ^[1] ; Sengupta,S. ^[2] ; Balekudaru,S. ; Shah,J. ; George,R. ; Lingam,V.

作者单位： Aravind Eye Hospital, Thavalakuppam, Puducherry, India ^[1] Medical Research Foundation Sankara Nethralaya, Chennai, Tamil Nadu, India ^[2]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of glaucoma

2013年22卷3期

266-267页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Journal of glaucoma

2013年22卷3期

266-267页

检索历史清除

Reply to "safety and efficacy of using off-label bevacizumab versus mitomycin c to prevent bleb failure in a single site phacotrabeculectomy by a randomized controlled clinical trial"

Journal of glaucoma

相似文献

同项目论文

Journal of glaucoma

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Reply to "safety and efficacy of using off-label bevacizumab versus mitomycin c to prevent bleb failure in a single site phacotrabeculectomy by a randomized controlled clinical trial"

Journal of glaucoma

相似文献

同项目论文

Journal of glaucoma

相关期刊

检索历史清除